Development of 166 Holmium-1,2 Propylene Di-amino Tetra (Methy1enephosphonicacid) as a Possible Bone Palliation Agent
Main Authors: | Samaneh Zolghadri, Amir Reza Jalilian, Hassan Yousefnia, Ali Bahrami-Samani, Mohammad Ghannadi-Maragheh |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2014-01-01
|
Series: | World Journal of Nuclear Medicine |
Online Access: | http://www.wjnm.org/article.asp?issn=1450-1147;year=2014;volume=13;issue=1;spage=28;epage=33;aulast=Zolghadri |
Similar Items
-
Retraction: Development of 166 Holmium-1,2 Propylene Di-amino Tetra (Methy1enephosphonicacid) as a Possible Bone Palliation Agent
Published: (2016-01-01) -
Production, Quality Control and Biological Evaluation of 166Ho-PDTMP as a Possible Bone Palliation Agent
by: Samaneh Zolghadri, et al.
Published: (2013-05-01) -
Production, biodistribution assessment and dosimetric evaluation of 177Lu-TTHMP as a bone pain palliation agent
by: samaneh zolghadri, et al.
Published: (2015-01-01) -
Production, biodistribution assessment and dosimetric evaluation of 177Lu-TTHMP as a bone pain palliation agent
by: samaneh zolghadri, et al.
Published: (2015-01-01) -
Production, quality control, biodistribution assessment and preliminary dose evaluation of [177Lu]-tetra phenyl porphyrin complex as a possible therapeutic agent
by: Samaneh Zolghadri, et al.
Published: (2015-06-01)